Respiratory Devices and Equipment (Therapeutic) Market Report 2025

This Respiratory Devices and Equipment (Therapeutic) market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The respiratory devices and equipment (therapeutic) market size has grown strongly in recent years. It will grow from $21.07 billion in 2024 to $23.04 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to respiratory conditions prevalence, aging population, technological advancements, respiratory disease management.

The respiratory devices and equipment (therapeutic) market size is expected to see strong growth in the next few years. It will grow to $32.93 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to chronic diseases and lifestyle factors, telehealth expansion, technological innovations, copd management. Major trends in the forecast period include digital health and remote monitoring, ventilators and life support systems, respiratory rehabilitation, telehealth integration.

The therapeutic respiratory devices and equipment market has experienced growth, driven by the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disorder (COPD) and sleep apnea. These conditions have a significant global impact, with COPD ranking as the third leading cause of death worldwide, resulting in one million deaths attributed to tobacco consumption out of 4.9 million deaths. The aging population is particularly affected, with diseases like tuberculosis, COPD, and lung cancer expected to account for about one in five deaths globally by 2030. In the United States, the Centers for Disease Control and Prevention (CDC) reported that 9 million adults were diagnosed with chronic bronchitis. Sleep apnea also poses a challenge, with an estimated 22 million Americans suffering from this condition, of which 80% remain undiagnosed. Globally, the prevalence of obstructive sleep apnea was found to be around 20%. These rising disease cases among the elderly population are driving the growth of the therapeutic respiratory devices and equipment market.

The increasing number of smokers is expected to contribute to the growth of the therapeutic respiratory devices and equipment market. Smokers, who use tobacco products such as cigarettes, cigars, or pipes, often require respiratory devices and equipment like inhalers and nebulizers to manage conditions like COPD, chronic bronchitis, and lung cancer. For example, in July 2022, cigarette production in Canada increased by 5.8% compared to the previous year, with total cigarette sales rising by 1.3% in June 2022, reaching 1.4 billion. This increase in the number of smokers is fueling the demand for therapeutic respiratory devices and equipment.

Companies in the market are increasingly incorporating artificial intelligence (AI) into the development of respiratory devices for conditions like Asthma and COPD. AI-driven sensors-equipped inhalers help patients monitor their dosage intake and track their respiratory patterns. These advanced devices can automatically collect data and provide alerts to both healthcare providers and patients regarding their health status. Some companies are also working on AI-aided imaging systems and AI-aided platforms, acting as voice biomarkers. For example, in March 2022, Respira Labs, a U.S.-based respiratory technology company, introduced 'sylvee,' an AI-powered wearable lung monitor that uses acoustic resonance to assess lung function and detect variations.

Major companies operating in the therapeutic respiratory devices and equipment market are focusing on product innovation to deliver reliable services to customers. The VitaloPFT series, launched by Vitalograph Ltd., is designed to offer advanced respiratory diagnostic solutions, including point-of-care testing for patients. The series caters to hospitals and secondary care units, providing comprehensive pulmonary function testing. For instance, in March 2023, Vitalograph Ltd. introduced the VitaloPFT series, which includes the VitaloROV+, a portable pulmonary function testing (PFT) device for accurate point-of-care testing.

In May 2023, SunMed, a US-based medical device manufacturing company, acquired the respiratory and anesthesia consumables business unit from Vyaire Medical for an undisclosed amount. This acquisition positions SunMed as a leading manufacturer in airway management and anesthesia care, expanding its product offerings and enhancing manufacturing reliability. By integrating expertise, the company aims to drive innovation and improve patient outcomes, establishing new benchmarks in healthcare. Vyaire Medical is a US-based medical equipment manufacturing company specializing in airway management and operative care technology, including respiratory and anesthesia consumables.

Respiratory devices and equipment in the therapeutic category are essential for treating patients with acute or chronic respiratory disorders, including conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, and sleep disorders.

The primary products within the respiratory devices and equipment (therapeutic) market encompass nebulizers, humidifiers, oxygen concentrators, positive airway pressure devices, ventilators, capnographs, and gas analyzers. Nebulizers, for instance, are small devices that convert liquid medicine into a mist, which is then inhaled by patients through a connected mouthpiece. Various technologies are employed in these respiratory devices and equipment, including HEPA filters, electrostatic filtration, microsphere separation, hollow fiber filtration, and other filtration methods. The market for these therapeutic devices is segmented based on end-users, with applications in both home care settings and hospitals.

The respiratory devices and equipment (therapeutic) market research report is one of a series of new reports that provides respiratory devices and equipment (therapeutic) market statistics, including respiratory devices and equipment (therapeutic) industry global market size, regional shares, competitors with a respiratory devices and equipment (therapeutic) market share, detailed respiratory devices and equipment (therapeutic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (therapeutic) industry. This respiratory devices and equipment (therapeutic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the respiratory devices and equipment (therapeutic) market include Hamilton Medical AG, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Philips Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Drägerwerk AG & Co. KGaA, Medtronic PLC, Masimo Corporation, CareFusion Corporation, Getinge AB, Hill-Rom Holdings Inc., Becton, Dickinson and Company, Air Liquide S.A., Vyaire Medical Inc., Compumedics Limited, Covidien PLC, Mindray Medical International Limited, Inogen Inc., Nihon Kohden Corporation, Siemens Healthcare GmbH, Teleflex Incorporated, Breas Medical AB, AirSep Corporation, Rotech Healthcare Inc., 3B Medical Inc.

Asia-Pacific was the largest region in the respiratory devices and equipment (therapeutic) market in 2024. Western Europe was the second-largest region in the respiratory devices and equipment (therapeutic) market. The regions covered in the respiratory devices and equipment (therapeutic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory devices and equipment (therapeutic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The respiratory devices and equipment (therapeutic) market consist of sales of instruments such as nebulizers, oxygen concentrators, positive airway pressure devices, ventilators, inhalers, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.